Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
30
Sep |
BARDA Funds Development Of Next-Generation Portable VentilatorsCategory: Medical Devices / Diagnostics | Leave a Comment |
A $6.7 million contract announced by the U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) will help fill the need for domestically manufactured, low-cost, user-friendly and flexible next-generation ventilators. This contract to Newport Medical Instruments of Costa Mesa, Calif., is for three years…
|
30
Sep |
2010 AAO-HNSF Miniseminars: Wednesday, Sept. 29, 2010Category: Ear, Nose and Throat | Leave a Comment |
The 2010 Annual Meeting & OTO EXPO of the American Academy of Otolaryngology - Head and Neck Surgery Foundation (AAO-HNSF), the largest meeting of ear, nose, and throat doctors in the world, convened September 26-29, 2010, in Boston, MA…
|
30
Sep |
Early Detection Of Lung Cancer Using Cheek SwabCategory: Lung Cancer | Leave a Comment |
Early detection is critical for improving cancer survival rates. Yet, one of the deadliest cancers in the United States, lung cancer, is notoriously difficult to detect in its early stages. Now, researchers have developed a method to detect lung cancer by merely shining diffuse light on cells swabbed from patients’ cheeks…
|
30
Sep |
Novel Test Following Prostate Surgery Could Detect Cancer Recurrence EarlierCategory: Prostate / Prostate Cancer | Leave a Comment |
A new test could reliably detect early increases in prostate specific antigen (PSA) levels - a biomarker commonly used to measure the recurrence of prostate cancer - in men who have undergone prostate cancer-treating surgery. Earlier detection of these rising levels would allow men with cancer recurrence to undergo earlier, more effective treatment for potentially better outcomes…
|
30
Sep |
A Small Blood Sample Is All That’s Needed To Detect Colorectal Cancer With New Screening ToolCategory: Colorectal Cancer | Leave a Comment |
A new microRNA (miRNA) screening assay detected the majority of early-stage colorectal cancers with good specificity and sensitivity. “Our test has the potential to be safe, cheap, robust, accurate and of little or no inconvenience to the individual, and could, therefore, easily be integrated into national screening programs as part of an annual checkup,” said Søren Jensby Nielsen, Ph.D…
|
30
Sep |
Breast Cancer Cells Efficiently Collected By Dual-Capture CTC ChipCategory: Breast Cancer | Leave a Comment |
Researchers have identified a novel, dual-platform technology, the On-Q-ity Circulating Cancer Capture and Characterization Chip (C5), which they believe is more efficient than the commonly used single-platform device in identifying circulating tumor cells (CTCs) in breast cancer…
|
30
Sep |
Tracking Down Pathogenic YeastsCategory: Infectious Diseases / Bacteria / Viruses | Leave a Comment |
More than half of all people are hosts to Candida albicans in their bodies. This species might be located on their skin or mucous membranes or in the intestines - frequently without causing any symptoms. However, it can be dangerous to patients whose immunological system has been weakened such as after organ transplants or chemotherapy with cancer…
|
30
Sep |
Microfluidics Device For Identifying Aggressive Breast CancersCategory: Breast Cancer | Leave a Comment |
A new disposable device based on advances in microfluidics may help identify advanced breast cancer patients who are candidates for therapy with the drug trastuzumab (Herceptin). The device is described in the American Institute of Physics’ journal Biomicrofluidics…
|
29
Sep |
New Prostate Cancer Test Could Be 90 Per Cent AccurateCategory: Prostate / Prostate Cancer | Leave a Comment |
According to early findings of a pilot study presented at a conference in the US this week, the controversy surrounding prostate cancer screening could be about to change: a UK company has developed a panel of biomarkers that appears to distinguish samples of prostate cancer from samples of benign prostate disease and healthy prostate tissue 90 per cent of the time, …
|
29
Sep |
Incidental Medical Imaging Test Findings, What Is The Correct Approach?Category: MRI / PET / Ultrasound | Leave a Comment |
In over one third of all cases in which patients partake in a medical imaging procedure, an actual 40% display tumors or infections that are unrelated to the original need for the initial imaging…